atai Life Sciences to Participate in November Investor Events & Healthcare Conferences
02 November 2022 - 3:00AM
atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage
biopharmaceutical company aiming to transform the treatment of
mental health disorders, will participate in the following
investor events & healthcare conferences:
- Financial Times Pharma and Biotech Summit in
LondonFormat: Industry PanelDate and Time: Wednesday,
November 9th, 9:55 a.m. – 10:40 a.m. ETConference link: Financial
Times’ Pharma and Biotech Summit
- Credit Suisse Annual Healthcare Conference in Southern
CaliforniaFormat: Fireside ChatDate and Time: Wednesday,
November 9th, 4:35 p.m. – 6:35 p.m. ETConference link: Credit
Suisse Annual Healthcare Conference
- HLTH in Las VegasFormat: Industry PanelDate
and Time: Monday, November 14th, 7:20 p.m. - 8:00 p.m. ETConference
link: HLTH
- Jefferies Healthcare Conference in
LondonFormat: Fireside ChatDate and Time: Wednesday,
November 16th, 8:00 a.m. – 8:30 a.m. GMTConference link: Jefferies
London Healthcare Conference
- Collaborating for Novel Solutions (CNS) Summit in Boca
Raton, FloridaFormat: Keynote Industry PanelDate and Time:
Saturday, November 19th, 12 p.m. – 12:30 p.m. ETConference link:
Collaborating for Novel Solutions Summit
Certain events will have archived webcasts available in the
Events section of atai’s website at https://www.atai.life, where
they will be available for up to 90 days.
About atai Life Sciencesatai Life Sciences is a
clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders. Founded in 2018 as a response
to the significant unmet need and lack of innovation in the mental
health treatment landscape, atai is dedicated to acquiring,
incubating, and efficiently developing innovative therapeutics to
treat depression, anxiety, addiction, and other mental health
disorders.
By pooling resources and best practices, atai aims to
responsibly accelerate the development of new medicines across its
companies to achieve clinically meaningful and sustained behavioral
change in mental health patients.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. For more
information, please visit www.atai.life
Contact Information
Investor Contact:Stephen BardinChief Financial OfficerEmail:
IR@atai.life
Media Contact:Allan MalievskySenior Director of External
AffairsEmail: PR@atai.life
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2024 to Apr 2024
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Apr 2023 to Apr 2024